Sympathetic hyperactivity and cardiac dysfunction post-MI: Different impact of specific CNS versus general AT1 receptor blockade
- 31 October 2007
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 43 (4) , 479-486
- https://doi.org/10.1016/j.yjmcc.2007.07.047
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Heart and Stroke Foundation of Canada (-13182)
- Pfizer Canada
This publication has 10 references indexed in Scilit:
- Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogenJournal of Molecular and Cellular Cardiology, 2005
- Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in ratsCardiovascular Research, 2004
- Effects of differential blockade of the renin‐angiotensin system in postinfarcted ratsFundamental & Clinical Pharmacology, 2004
- Prevention of Sympathetic and Cardiac Dysfunction After Myocardial Infarction in Transgenic Rats Deficient in Brain AngiotensinogenCirculation Research, 2004
- AT1‐receptor blockade and sympathetic neurotransmission in cardiovascular diseaseAutonomic & Autacoid Pharmacology, 2003
- Early and chronic captopril or Losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in ratsArchives of Medical Research, 2003
- Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartanCardiovascular Research, 2003
- Central Nervous System Blockade by Peripheral Administration of AT1 Receptor BlockersJournal of Cardiovascular Pharmacology, 2003
- Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophyJournal of Molecular Medicine, 2001
- Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptorsBrain Research, 2000